Alliance Healthcare continues to defend UK antitrust charges over drug deals (correct*)
Alliance Healthcare "continues to defend" itself against UK charges of infringing competition law in deals to acquire the antibiotic Nitrofurantoin, according to a US securities filing submitted by AmerisourceBergen, which plans...To view the full article, register now.
Already a subscriber? Click here to view full article